be visible on the BioBusiness market ISSN 2300-0228
Find us on:
Pivotal announces participation in two clinical trials with a novel investigational immunotherapy drug to treat melanoma and lung cancer
Impressions from the visit to Wageningen, the specter of famine, CRISPR Cas9 to the rescue!
Reach out to potential partners and customers in the Danish-Swedish life science cluster, Medicon Valley
Central European Healthcare Expo (20-21.05.2020 Global Expo Warsaw)
The world of healthcare ...
Tag: Hexaell Biotechnologies
Show search box
Publish date from
Shanghai-Based Hexaell Biotech Secures 50 million RMB ($7.3 million) Series A Financing From Hyfinity Investments
The funding will be used to support the clinical and CFDA registration of the hiHep cell engineering system and further accelerate Hexaell's research and development in liver diseases and cell engineering pipeline ...
The most popular tags